Efeito do tratamento com dose reduzida do aglepristone em uma hiperplasia mamaria felina: Relato de caso / Effect of the treatment with low dose of aglepristone in a feline mammary hyperplasia: case report
Silva, Paula Barbosa Da; Cavalho, Elaine Lopes De; Oliveira Neta, Anália Costa De; Chaves Neto, Álvaro; Lima, Wilton Figueiredo; Silva, Gustavo Alighiere Lopes Da; Fernandes, Natacha Cintia Ferreira; Ribeiro, Haroldo Francisco Lobato.
R. bras. Reprod. Anim.;
40(4): 541-542, Out-Dez. 2016.
Artigo
em Português
| VETINDEX
| ID: vti-24244
Resumo
Feline mammary hyperplasia (FMH) is a benign condition representing a disorder of body related tonatural or synthetic progestogen characterized by rapid cell growth of one or more mammary glands. Havingrapidly evolving and can cause serious systemic changes, it is necessary to use instant protocols, such as the useof aglepristone an antiprogestogen. This study aims to report a case of FMH with aglepristone-based therapy. Acat mongrel, with 9 months old, nulliparous, who received a contraceptive dose, showed an increase in thethoracic right mammary gland M1. The history and physical examination indicated the diagnosis of FMH. Thetherapy established was aglepristone in 3 doses (10mg / kg) every 24 hours. The result was total remission ofsymptoms. The use of aglepristone proved to be effective in the treatment of FMH even without castration.(AU)
Biblioteca responsável:
BR68.1
Localização: BR68.1
Texto completo